Venetoclax and Decitabine in Treating Participants With Relapsed/Refractory Acute Myeloid Leukemia or Relapsed High-Risk Myelodysplastic Syndrome
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
NextCure, Inc.
Novartis
Kahr Medical
Servier
Amgen
Roswell Park Cancer Institute
M.D. Anderson Cancer Center
Merck Sharp & Dohme LLC